The efficacy and safety of the dipeptidyl peptidase-4 inhibitor saxagliptin in treatment-na？ve patients with type 2 diabetes mellitus a randomized controlled trial 英文参考文献.docVIP

下载本文档

9
0
约5.17万字
约 12页
2017-05-13 发布于上海
举报

The efficacy and safety of the dipeptidyl peptidase-4 inhibitor saxagliptin in treatment-na？ve patients with type 2 diabetes mellitus a randomized controlled trial 英文参考文献.doc

The efficacy and safety of the dipeptidyl peptidase-4 inhibitor saxagliptin in treatment-na？ve patients with type 2 diabetes mellitus a randomized controlled trial 英文参考文献

Frederichetal.DiabetologyMetabolicSyndrome2012,4:36 /content/4/1/36 DIABETOLOGY METABOLIC SYNDROME RESEARCH OpenAccess Theefficacyandsafetyofthedipeptidyl peptidase-4inhibitorsaxagliptinin treatment-na?vepatientswithtype2diabetes mellitus:arandomizedcontrolledtrial RobertFrederich1*,RobertMcNeill2,NiklasBerglind3,DouglasFleming1andRolandChen1 Abstract Background:Theaimofthisstudywastoassessefficacyandsafetyofsaxagliptinmonotherapyforupto76weeks inpatientswithtype2diabetesmellitus(T2DM)andinadequateglycemiccontrol,withmainefficacyassessmentat 24weeks. Methods:365treatment-na?vepatientswithT

您可能关注的文档

文档评论（0）

1亿VIP精品文档

更多 >

The efficacy and safety of the dipeptidyl peptidase-4 inhibitor saxagliptin in treatment-na？ve patients with type 2 diabetes mellitus a randomized controlled trial 英文参考文献.docVIP